Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited (India) holds 1 active US FDA Type II Drug Master File and is linked to 5 FDA-registered manufacturing sites. 35 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Eugia Pharma Specialities Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/eugia-pharma-specialities-limited

Overview

Pharmaceutical manufacturing site surfaced via EU GMP non-compliance screening (EudraGMDP).

Core services & business areas

Pharmaceutical Manufacturing

API / Drug Master Files

Eugia Pharma Specialities Limited holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MEROPENEM FOR INJECTION (STERILE BULK)Active2013-06-18

Registered manufacturing sites (5)

Physical sites registered with the US FDA and resolved to Eugia Pharma Specialities Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

35 FDA enforcement records linked to this company.

  • warning_letter2026-08-13

    FDA Warning Letter (drug product)

  • eu_noncompliance2026-03-27

    EU GMP Statement of Non-Compliance

  • 4832026-02-06

    Environmental Monitoring System

  • 4832026-02-06

    Following/documenting laboratory controls

  • 4832026-02-06

    Procedures for sterile drug products

  • 4832026-02-06

    Testing and release for distribution

  • 4832026-02-06

    Training--operations, GMPs, written procedures

  • 4832026-02-06

    Validation lacking for sterile drug products

  • 4832026-02-06

    Second person sign off

  • 4832026-02-06

    Investigations of discrepancies, failures

  • 4832026-02-06

    Procedures not in writing, fully followed

  • 4832026-02-06

    Sterility/pyrogens - test methods written, followed

  • 4832026-02-06

    Equipment to control conditions

  • warning_letter2024-08-15

    FDA Warning Letter (drug product)

  • 4832024-05-03

    Mfg / Processing Operations Area

  • 4832024-05-03

    Procedures for sterile drug products

  • 4832024-05-03

    Validation lacking for sterile drug products

  • 4832024-05-03

    Environmental Monitoring System

  • 4832024-05-03

    Cleaning System

  • 4832024-05-03

    Absence of Written Procedures

  • 4832024-05-03

    Investigations of discrepancies, failures

  • 4832024-02-02

    Computer control of master formula records

  • 4832024-02-02

    Scientifically sound laboratory controls

  • 4832024-02-02

    Changes to Procedures Not Reviewed, Approved

  • 4832024-02-02

    Investigations of discrepancies, failures

  • 4832024-02-02

    Prepared for each batch, include complete information

  • 4832024-02-02

    Absence of Written Procedures

  • 4832024-02-02

    Validation lacking for sterile drug products

  • 4832024-02-02

    Procedures for sterile drug products

  • 4832024-02-02

    Complete test data included in records

  • 4832018-12-14

    Procedures for sterile drug products

  • 4832018-12-14

    Protective Apparel Not Worn

  • 4832018-03-06

    Training , Education , Experience overall

  • 4832018-03-06

    Lab controls established, including changes

  • 4832018-03-06

    Absence of Written Procedures

For suppliers

Is this Eugia Pharma Specialities Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.